Alyeska Investment Group
PHAS

Alyeska Investment Group’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Alyeska Investment Group’s Portfolio PHAS Stock Details PHAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-68,054
Closed -$893K – 506
2019
Q2 		$893K Buy
+68,054
New +$893K 0.01% 339
2019
Q1 		– Sell
-191,602
Closed -$592K – 436
2018
Q4 		$592K Buy
+191,602
New +$592K 0.01% 292